Prognostic scores of patients with confirmed CML in CP at diagnosis
| . | Men, n = 373 . | Women, n = 326 . | P* . | Patients living in university hospital catchment areas, n = 257 . | Patients living in other areas, n = 442 . | P* . | Total, N = 699 . |
|---|---|---|---|---|---|---|---|
| Sokal score, no. (%) | |||||||
| Low risk | 94 (25.2) | 62 (19.0) | 64 (24.9) | 92 (20.8) | 156 (22.3) | ||
| Intermediate risk | 164 (44.0) | 136 (41.7) | 112 (43.6) | 188 (42.5) | 300 (42.9) | ||
| High risk | 104 (27.9) | 116 (35.6) | 78 (30.4) | 142 (32.1) | 220 (31.5) | ||
| Missing | 11 (2.9) | 12 (3.7) | .080 | 3 (1.2) | 20 (4.5) | .072 | 23 (3.3) |
| Hasford score, no. (%) | |||||||
| Low risk | 127 (34.0) | 85 (26.1) | 84 (32.7) | 128 (29.0) | 212 (30.3) | ||
| Intermediate risk | 172 (46.1) | 162 (49.7) | 120 (46.7) | 214 (48.4) | 334 (47.8) | ||
| High risk | 56 (15.0) | 63 (19.3) | 44 (17.1) | 75 (17.0) | 119 (17.0) | ||
| Missing | 18 (4.8) | 16 (4.9) | .111 | 9 (3.5) | 25 (5.7) | .494 | 34 (4.9) |
| EUTOS score, no. (%) | |||||||
| Low risk | 298 (79.9) | 271 (83.1) | 210 (81.7) | 359 (81.2) | 569 (81.4) | ||
| High risk | 57 (15.3) | 41 (12.6) | 38 (14.8) | 60 (13.6) | 98 (14.0) | ||
| Missing | 18 (4.8) | 14 (4.3) | .538 | 9 (3.5) | 23 (5.2) | .548 | 32 (4.6) |
| . | Men, n = 373 . | Women, n = 326 . | P* . | Patients living in university hospital catchment areas, n = 257 . | Patients living in other areas, n = 442 . | P* . | Total, N = 699 . |
|---|---|---|---|---|---|---|---|
| Sokal score, no. (%) | |||||||
| Low risk | 94 (25.2) | 62 (19.0) | 64 (24.9) | 92 (20.8) | 156 (22.3) | ||
| Intermediate risk | 164 (44.0) | 136 (41.7) | 112 (43.6) | 188 (42.5) | 300 (42.9) | ||
| High risk | 104 (27.9) | 116 (35.6) | 78 (30.4) | 142 (32.1) | 220 (31.5) | ||
| Missing | 11 (2.9) | 12 (3.7) | .080 | 3 (1.2) | 20 (4.5) | .072 | 23 (3.3) |
| Hasford score, no. (%) | |||||||
| Low risk | 127 (34.0) | 85 (26.1) | 84 (32.7) | 128 (29.0) | 212 (30.3) | ||
| Intermediate risk | 172 (46.1) | 162 (49.7) | 120 (46.7) | 214 (48.4) | 334 (47.8) | ||
| High risk | 56 (15.0) | 63 (19.3) | 44 (17.1) | 75 (17.0) | 119 (17.0) | ||
| Missing | 18 (4.8) | 16 (4.9) | .111 | 9 (3.5) | 25 (5.7) | .494 | 34 (4.9) |
| EUTOS score, no. (%) | |||||||
| Low risk | 298 (79.9) | 271 (83.1) | 210 (81.7) | 359 (81.2) | 569 (81.4) | ||
| High risk | 57 (15.3) | 41 (12.6) | 38 (14.8) | 60 (13.6) | 98 (14.0) | ||
| Missing | 18 (4.8) | 14 (4.3) | .538 | 9 (3.5) | 23 (5.2) | .548 | 32 (4.6) |
P value for the null hypothesis of no difference between the sexes or the patients’ area of residence.